Fig. 3
From: Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers
Cost-effectiveness of management without a multidisciplinary high-risk clinic. MDC multidisciplinary high-risk clinic, QALY quality-adjusted life-year.
